DCM
PMVP icon

Driehaus Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Driehaus Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35,000
Closed -$1.04M – 430
2021
Q3 		$1.04M Buy
+35,000
New +$1.12M 0.01% 322
2021
Q2 		– Sell
-215,307
Closed -$7.08M – 504
2021
Q1 		$7.08M Sell
215,307
-16,509
-7% -$651K 0.1% 249
2020
Q4 		$14.3M Sell
231,816
-5,747
-2% -$225K 0.23% 123
2020
Q3 		$8.43M Buy
+237,563
New +$8.74M 0.17% 151

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Driehaus Capital Management's PMVP Position: Q4 2021 in Review

Driehaus Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2021, closing a stake of 35,000 shares — an estimated $1.04M sold.

Driehaus Capital Management first reported a position in PMVP in Q3 2020 and held it in 4 quarters. The position peaked at $14.3M in Q4 2020. 105 funds tracked by Wall St. Rank hold PMVP as of Q4 2021.

  • Driehaus Capital Management reported no remaining PMV Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 35,000 PMV Pharmaceuticals shares in Q4 2021, an estimated $1.04M.
  • Driehaus Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Driehaus Capital Management's PMV Pharmaceuticals position peaked at $14.3M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2021.

Based on Driehaus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.